Levonorgestrel in Preventing Ovarian Cancer in Patients at High Risk for Ovarian Cancer
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Gustavo C Rodriguez
Gynecologic Oncology Group
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
66 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Usc / Norris Comprehensive Cancer Center
Los Angeles, California, United States
- Uc Irvine Health/chao Family Comprehensive Cancer Center
Orange, California, United States
- University of California San Diego
San Diego, California, United States
- Colorado Gynecologic Oncology Group
Aurora, Colorado, United States
- Memorial Health University Medical Center
Savannah, Georgia, United States
- Northwestern University
Chicago, Illinois, United States
- Northshore University Healthsystem-Evanston Hospital
Evanston, Illinois, United States
- Hinsdale Hematology Oncology Associates Incorporated
Hinsdale, Illinois, United States
- Sudarshan K Sharma Md Limited-Gynecologic Oncology
Hinsdale, Illinois, United States
- Elkhart Clinic
Elkhart, Indiana, United States
- Elkhart General Hospital
Elkhart, Indiana, United States
- Michiana Hematology Oncology Pc-Elkhart
Elkhart, Indiana, United States
- Indiana University/melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States
- Saint Vincent Hospital and Health Care Center
Indianapolis, Indiana, United States
- Iu Health la Porte Hospital
La Porte, Indiana, United States
- Michiana Hematology Oncology Pc-Mishawaka
Mishawaka, Indiana, United States
- Saint Joseph Regional Medical Center-Mishawaka
Mishawaka, Indiana, United States
- Michiana Hematology Oncology Pc-Plymouth
Plymouth, Indiana, United States
- Memorial Hospital of South Bend
South Bend, Indiana, United States
- Michiana Hematology Oncology Pc-South Bend
South Bend, Indiana, United States
- Northern Indiana Cancer Research Consortium
South Bend, Indiana, United States
- Michiana Hematology Oncology Pc-Westville
Westville, Indiana, United States
- Saint Elizabeth Medical Center South
Edgewood, Kentucky, United States
- Baptist Health Lexington
Lexington, Kentucky, United States
- Borgess Medical Center
Kalamazoo, Michigan, United States
- Bronson Methodist Hospital
Kalamazoo, Michigan, United States
- West Michigan Cancer Center
Kalamazoo, Michigan, United States
- Lakeland Hospital Niles
Niles, Michigan, United States
- Lakeland Medical Center Saint Joseph
Saint Joseph, Michigan, United States
- Marie Yeager Cancer Center
Saint Joseph, Michigan, United States
- University of Minnesota/masonic Cancer Center
Minneapolis, Minnesota, United States
- Cancer Research for the Ozarks Ncorp
Springfield, Missouri, United States
- Coxhealth South Hospital
Springfield, Missouri, United States
- Mercy Hospital Springfield
Springfield, Missouri, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Women'S Cancer Center of Nevada
Las Vegas, Nevada, United States
- Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, United States
- Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 10 Mar 2008
- Primary completion
- 11 Dec 2013
- Completion
- —
- Last update posted
- 19 Nov 2019
- Registered enrollment
- 60
- Registry id
- NCT00445887
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.